Skip to main content

Advertisement

Log in

Enhanced brain targeting efficiency of intranasally administered plasmid DNA: an alternative route for brain gene therapy

  • Original Article
  • Published:
Journal of Molecular Medicine Aims and scope Submit manuscript

Abstract

Recently, nasal administration has been studied as a noninvasive route for delivery of plasmid DNA encoding therapeutic or antigenic genes. Here, we examined the brain targeting efficiency and transport pathways of intranasally administered plasmid DNA. Quantitative polymerase chain reaction (PCR) measurements of plasmid DNA in blood and brain tissues revealed that intranasally administered pCMVβ (7.2 kb) and pN2/CMVβ (14.1 kb) showed systemic absorption and brain distribution. Following intranasal administration, the β-galactosidase protein encoded by these plasmids was significantly expressed in brain tissues. Kinetic studies showed that intranasally administered plasmid DNA reached the brain with a 2,595-fold higher efficiency than intravenously administered plasmid DNA did, 10 min post-dose. Over 1 h post-dose, the brain targeting efficiencies were consistently higher for intranasally administered plasmid DNA than for intravenously administered DNA. To examine how plasmid DNA enters the brain and moves to the various regions, we examined tissues from nine brain regions, at 5 and 10 min after intranasal or intravenous administration of plasmid DNA. Intravenously administered plasmid DNA displayed similar levels of plasmid DNA in the nine different regions, whereas, intranasally administered plasmid DNA exhibited different levels of distribution among the regions, with the highest plasmid DNA levels in the olfactory bulb. Moreover, plasmid DNA was mainly detected in the endothelial cells, but not in glial cells. Our results suggest that intranasally applied plasmid DNA may reach the brain through a direct route, possibly via the olfactory bulb, and that the nasal route might be an alternative method for efficiently delivering plasmid DNA to the brain.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7

Similar content being viewed by others

References

  1. Jia SF, Worth LL, Densmore CL, Xu B, Zhou Z, Kleinerman ES (2002) Eradication of osteosarcoma lung metastases following intranasal interleukin-12P gene therapy using a nonviral polyethylenimine vector. Cancer Gene Ther 9:260–266

    Article  PubMed  CAS  Google Scholar 

  2. Kitani A, Fuss IJ, Nakamura K, Schwartz OM, Usui T, Strober W (2000) Treatment of experimental (Trinitrobenzene sulfonic acid) colitis by intranasal administration of transforming growth factor (TGF)-beta1 plasmid: TGF-beta1-mediated suppression of T helper cell type 1 response occurs by interleukin (IL)-10 induction and IL-12 receptor beta2 chain downregulation. J Exp Med 192:41–52

    Article  PubMed  CAS  Google Scholar 

  3. Hyde SC, Southern KW, Gileadi U, Fitzjohn EM, Mofford KA, Waddell BE, Gooi HC, Goddard CA, Hannavy K, Smyth SE, Egan JJ, Sorgi FL, Huang L, Cuthbert AW, Evans MJ, Colledge WH, Higgins CF, Webb AK, Gill DR (2000) Repeat administration of DNA/liposomes to the nasal epithelium of patients with cystic fibrosis. Gene Ther 7:1156–1165

    Article  PubMed  CAS  Google Scholar 

  4. Minn A, Leclerc S, Heydel JM, Minn AL, Denizcot C, Cattarelli M, Netter P, Gradinaru D (2002) Drug transport into the mammalian brain: the nasal pathway and its specific metabolic barrier. J Drug Target 10:285–296

    PubMed  CAS  Google Scholar 

  5. Fisher RS, Ho J (2002) Potential new methods for antiepileptic drug delivery. CNS Drugs 16:579–593

    Article  PubMed  CAS  Google Scholar 

  6. Thorne RG, Frey WH (2001) Delivery of neurotrophic factors to the central nervous system: pharmacokinetic considerations. Clin Pharmacokinet 40:907–946

    Article  PubMed  CAS  Google Scholar 

  7. Born J, Lange T, Kern W, McGregor GP, Bickel U, Fehm HL (2002) Sniffing neuropeptides: a transnasal approach to the human brain. Nat Neurosci 5:514–516

    Article  PubMed  CAS  Google Scholar 

  8. De Rosa R, Garcia AA, Braschi C, Capsoni S, Maffei L, Berardi N, Cattaneo A (2005) Intranasal administration of nerve growth factor (NGF) rescues recognition memory deficits in AD11 anti-NGF transgenic mice. Proc Natl Acad Sci U S A 102:3811–3816

    Article  PubMed  CAS  Google Scholar 

  9. Oh YK, Kim JP, Hwang TS, Ko JJ, Kim JM, Yang JS, Kim CK (2001) Nasal absorption and biodistribution of plasmid DNA: an alternative route of DNA vaccine delivery. Vaccine 19: 4519–4525

    Article  PubMed  CAS  Google Scholar 

  10. Chun S, Daheshia M, Lee S, Eo SK, Rouse BT (1999) Distribution fate and mechanism of immune modulation following mucosal delivery of plasmid DNA encoding IL-10. J Immunol 163:2393–2402

    PubMed  CAS  Google Scholar 

  11. Oh YK, Suh D, Kim JM, Choi HG, Shin K, Ko JJ (2002) Polyethylenimine-mediated cellular uptake, nucleus trafficking and expression of cytokine plasmid DNA. Gene Ther 9:1627–1632

    Article  PubMed  CAS  Google Scholar 

  12. Zerbini M, Gallinella G, Manaresi E, Musiani M, Gentilomi G, Venturoli S (1999) Standardization of a PCR-ELISA in serum samples: diagnosis of active parvovirus B19 infection. J Med Virol 59:239–244

    Article  PubMed  CAS  Google Scholar 

  13. Kang MJ, Kim CK, Kim MY, Hwang TS, Kang SY, Kim WK, Ko JJ, Oh YK (2004) Skin permeation, biodistribution, and expression of topically applied plasmid DNA. J Gene Med 6:1238–1246

    Article  PubMed  CAS  Google Scholar 

  14. Ichikawa N, Naora K, Hirano H, Hashimoto M, Masumura S, Iwamoto K (1996) Isolation and primary culture of rat cerebral microvascular endothelial cells for studying drug transport in vitro. J Pharmacol Toxicol Methods 36:45–52

    Article  PubMed  CAS  Google Scholar 

  15. Stein VM, Czub M, Hansen R, Leibold W, Moore PF, Zurbriggen A, Tipold A (2004) Characterization of canine microglial cells isolated ex vivo. Vet Immunol Immunopathol 99:73–85

    Article  PubMed  CAS  Google Scholar 

  16. Oh YK, Kim JP, Yoon H, Kim JM, Yang JS, Kim CK (2001) Prolonged organ retention and safety of plasmid DNA administered in polyethylenimine complexes. Gene Ther 8:1587–1592

    Article  PubMed  CAS  Google Scholar 

  17. Roon KI, Soons PA, Uitendaal MP, de Beukelaar F, Ferrari MD (1999) Pharmacokinetic profile of alniditan nasal spray during and outside migraine attacks. Br J Clin Pharmacol 47:285–290

    Article  PubMed  CAS  Google Scholar 

  18. Nishikawa M, Takemura S, Kadakura Y, Hashida M (1998) Targeted delivery of plasmid DNA to hepatocytes in vivo: optimization of the pharmacokinetics of plasmid DNA/galactosylated poly(l-lysine) complexes by controlling their physicochemical properties. J Pharm Exp Ther 287:408–415

    CAS  Google Scholar 

  19. Graff CL, Pollack GM (2005) Nasal drug administration: potential for targeted central nervous system delivery. J Pharm Sci 94:1187–1195

    Article  PubMed  CAS  Google Scholar 

  20. Thorne RG, Pronk GJ, Padmanabhan V, Frey WH (2004) Delivery of insulin-like growth factor-I to the rat brain and spinal cord along olfactory and trigeminal pathways following intranasal administration. Neuroscience 127:481–496

    Article  PubMed  CAS  Google Scholar 

  21. Provost N, Le Meur G, Weber M, Mendes-Madeira A, Podevin G, Cherel Y, Colle MA, Deschamps JY, Moullier P, Rolling F (2005) Biodistribution of rAAV vectors following intraocular administration: evidence for the presence and persistence of vector DNA in the optic nerve and in the brain. Mol Ther 11:275–283

    Article  PubMed  CAS  Google Scholar 

  22. Tuszynski MH, Thal L, Pay M, Salmon DP, U HS, Bakay R, Patel P, Blesch A, Vahlsing HL, Ho G, Tong G, Potkin SG, Fallon J, Hansen L, Mufson EJ, Kordower JH, Gall C, Conner J (2005) A phase 1 clinical trial of nerve growth factor gene therapy for Alzheimer disease. Nat Med 11:551–555

    Article  PubMed  CAS  Google Scholar 

  23. Carlsson T, Winkler C, Burger C, Muzyczka N, Mandel RJ, Cenci A, Bjorklund A, Kirik D (2005) Reversal of dyskinesias in an animal model of Parkinson’s disease by continuous l-DOPA delivery using rAAV vectors. Brain 128:559–569

    Article  PubMed  Google Scholar 

  24. Tanaka SI, Yamakawa T, Kimura M, Aoki I, Kamei J, Okuda K, Mobbs C (2004) Daily nasal inoculation with the insulin gene ameliorates diabetes in mice. Diabetes Res Clin Pract 63:1–9

    Article  PubMed  CAS  Google Scholar 

  25. Devito C, Zuber B, Schroder U, Benthin R, Okuda K, Broliden K, Wahren B, Hinkula J (2004) Intranasal HIV-1-gp160-DNA/gp41 peptide prime-boost immunization regimen in mice results in long-term HIV-1 neutralizing humoral mucosal and systemic immunity. J Immunol 173:7078–7089

    PubMed  CAS  Google Scholar 

  26. Hino T, Yokota T, Ito S, Nishina K, Kang YS, Mori S, Hori S, Kanda T, Terasaki T, Mizusawa H (2006) In vivo delivery of small interfering RNA targeting brain capillary endothelial cells. Biochem Biophys Res Commun 340:263–267

    Article  PubMed  CAS  Google Scholar 

  27. Djupesland PG, Skretting A, Winderen M, Holand T (2004) Bi-directional nasal delivery of aerosols can prevent lung deposition. J Aerosol Med 17:249–259

    Article  PubMed  CAS  Google Scholar 

  28. Newman SP, Pitcairn GR, Dalby RN (2004) Drug delivery to the nasal cavity: in vitro and in vivo assessment. Crit Rev Ther Drug Carr Syst 21:21–66

    Google Scholar 

Download references

Acknowledgments

This research was financially supported by grants from Ministry of Science and Technology (F104AA010002-06A0101-00210), and from the Korea Science and Engineering Foundation (KOSEF R01-2005-000-10292-0).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Yu-Kyoung Oh.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Han, IK., Kim, M.Y., Byun, HM. et al. Enhanced brain targeting efficiency of intranasally administered plasmid DNA: an alternative route for brain gene therapy. J Mol Med 85, 75–83 (2007). https://doi.org/10.1007/s00109-006-0114-9

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00109-006-0114-9

Keywords

Navigation